Effects of primary and secondary low-grade respiratory syncytial virus infections in a murine model of asthma
Article first published online: 4 AUG 2004
Clinical & Experimental Allergy
Volume 34, Issue 8, pages 1307–1313, August 2004
How to Cite
Kondo, Y., Matsuse, H., Machida, I., Kawano, T., Saeki, S., Tomari, S., Obase, Y., Fukushima, C. and Kohno, S. (2004), Effects of primary and secondary low-grade respiratory syncytial virus infections in a murine model of asthma. Clinical & Experimental Allergy, 34: 1307–1313. doi: 10.1111/j.1365-2222.2004.02033.x
- Issue published online: 4 AUG 2004
- Article first published online: 4 AUG 2004
- Submitted 12 November 2003; revised 14 April 2004; accepted 19 May 2004
- airway inflammation;
- Dermatophagoides farinae;
- low-grade infection;
- respiratory syncytial virus
Background Respiratory syncytial virus (RSV) infection is known to develop and exacerbate asthma in young children. In adult, RSV causes recurrent but asymptomatic infections. However, the impact of asymptomatic RSV infection on adult asthma is yet to be determined. The present study is designed to determine the effects of primary and secondary low-grade RSV infections on allergic airway inflammation in a murine model of allergic asthma.
Methods A low-grade RSV (2 × 103 plaque-forming units/mouse) was inoculated, and this caused neither pulmonary inflammation nor symptoms but induced significant IFN-γ production in thoracic lymph nodes. To investigate interaction between low-grade virus and Dermatophagoides farinae (Df), airway hyper-responsiveness, lung inflammation and cytokine production from thoracic lymph nodes were compared after primary and secondary low-grade RSV infections in four groups of mice; control, Df allergen-sensitized, RSV-infected and Df-sensitized RSV-infected mice. A direct comparison between low- and high-grade RSV infections was also performed in primary infection. To investigate the role of IL-5 during secondary RSV infection, anti-IL-5 monoclonal antibody (anti-IL-5 mAb) was injected in mice and similar parameters were compared in four groups of mice.
Results Primary high-grade RSV infection increased allergen-induced airway inflammation, while primary low-grade RSV infection attenuated allergen-induced airway inflammation concomitant with significant IFN-γ production in lung-draining lymph nodes. In marked contrast, secondary low-grade RSV infection increased both IFN-γ and IL-5 production, resulting in exacerbation of allergen-induced airway inflammation. Anti-IL-5 mAb treatment in secondary low-grade RSV infection and Df allergen-sensitized mice attenuated virus and allergen-induced airway inflammation.
Conclusions Low-grade RSV infection per se does not cause pulmonary inflammation, whereas it induces a significant immunological response in the allergen-sensitized host. These results indicate that subclinical and recurrent RSV infection may play an important role in exacerbation and maintenance of asthma in adults, wherein IL-5 is critically involved.